Revolutionizing Bone Grafting with Backpack®
Ventris Medical, a prominent name in orthobiologics and tissue regeneration, has received a significant boost in its innovative journey. The United States Food and Drug Administration has cleared the Backpack® Bone Graft Containment System, marking a noteworthy advancement in the area of bone graft technology. This system, along with its dual versions, is tailored for orthopedic and spinal fusion procedures.
Understanding Backpack® Technology
The Backpack® system introduces a new class of biomaterials, emphasizing optimization in both cell proliferation and bone formation. It comes in two distinct versions. The first consists of a collagen mesh pouch filled with osteoinductive Allocell® AF fibers, while the second option features a pouch prefilled with Amplify® granules that are surface activated. Both are designed to improve surgical outcomes and promote healing.
Backpack® AF: A Groundbreaking Option
In the Backpack® AF configuration, the osteoinductive allograft fibers have found a perfect containment solution in the collagen mesh pouch. This innovative graft system is noteworthy as it allows both the pouch and the allograft fibers to participate actively in the bone remodeling process. The scaffold-like structure of the Allocell® AF fibers ensures that bone cells can attach, proliferate, and contribute to the natural healing process effectively. Furthermore, the osteoinductive properties support the differentiation of stem cells, leading to robust bone regeneration.
Simplifying Surgical Processes
Backpack® AF is conveniently supplied in a ported pouch, allowing for simple hydration before use, which streamlines the surgical procedures for healthcare professionals. By minimizing the complexity involved, this system aids surgeons in focusing on the patient's needs during challenging procedures.
Backpack® AMP: Enhanced Performance
The Backpack® AMP variant offers a unique blend of surface-activated Amplify® granules protected within the collagen mesh. This hybrid formulation combines two different resorbable materials with distinct rates of degradation, enhancing the healing environment at the fusion site. The formula consists of a mixture of HA-to-?TCP ratios that allows for a bimodal dissolution profile, facilitating nourishment during early healing stages and supporting ongoing bone remodeling.
Advantages for Patients and Surgeons
Similar to its brother, Backpack® AMP is presented in a ported pouch for ease of hydration and readiness for use in surgical situations. Both systems are poised to facilitate improved outcomes in orthopedic and spinal procedures, demonstrating Ventris Medical's commitment to advancing the field of regenerative medicine.
Leadership Perspectives on FDA Clearance
Russell Cook, CEO of Ventris Medical, expressed excitement about receiving FDA clearance, emphasizing the significance of this event. He shared, "This graft containment technology is unprecedented and paves the way for enhanced bone graft options in the market. The combination of osteoinductive fibers and surface-activated mineral components in a biologic containment system offers anti-migration benefits that have been absent in previous products." Cook's vision for Ventris Medical centers around continuing innovation and meeting the evolving needs of surgeons and distribution partners.
The Future of Orthobiologics
John Brunelle, PhD, COO of Ventris Medical, highlighted the advanced technology in the Backpack® platform, focusing on how it enhances the surgical experience and fusion outcomes. The sophisticated design ensures accurate delivery and retention of components, fostering a consistent healing response. This key milestone reaffirms Ventris Medical's role as a pioneering force in the orthobiologics industry, setting the stage for future innovations.
About Ventris Medical
Ventris Medical is committed to enhancing patient care through the development of innovative, proprietary platforms for tissue regeneration and bioresorbable bone graft products. With a focused mission on improving spinal and orthopedic fusion procedures, Ventris is dedicated to pioneering the next generation of medical solutions.
For further inquiries about Ventris Medical, individuals can find more information on their official website.
Frequently Asked Questions
What is the Backpack® Bone Graft Containment System?
The Backpack® system is a new type of biologic solution designed to optimize bone healing in orthopedic and spinal fusion surgeries, featuring innovative materials prefilled into a collagen mesh pouch.
How does the Backpack® AF variant work?
Backpack® AF contains osteoinductive allograft fibers enclosed in a collagen pouch, which promotes attachment and proliferation of bone cells, aiding the healing process.
What is the primary difference between Backpack® AF and Backpack® AMP?
Backpack® AF uses allograft fibers, whereas Backpack® AMP features surface-activated granules that have distinct resorption rates for enhanced healing at the fusion site.
How does Ventris Medical ensure the efficacy of these systems?
Ventris Medical combines heavily studied components with advanced containment technology to enhance surgical outcomes and provide a consistent healing environment.
What is the company vision of Ventris Medical?
Ventris Medical aims to innovate continuously in the field of orthobiologics to meet the needs of healthcare providers and improve patient care through advanced medical devices.
